OTCPK:CVSI

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

CV Sciences, Inc. operates as a life science company.


Snowflake Analysis

Excellent balance sheet and slightly overvalued.


Similar Companies

Share Price & News

How has CV Sciences's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CVSI's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

14.8%

CVSI

2.4%

US Personal Products

1.3%

US Market


1 Year Return

-83.9%

CVSI

-0.8%

US Personal Products

14.9%

US Market

Return vs Industry: CVSI underperformed the US Personal Products industry which returned -0.8% over the past year.

Return vs Market: CVSI underperformed the US Market which returned 14.9% over the past year.


Shareholder returns

CVSIIndustryMarket
7 Day14.8%2.4%1.3%
30 Day9.7%1.6%4.7%
90 Day46.7%12.7%17.1%
1 Year-83.9%-83.9%0.3%-0.8%17.3%14.9%
3 Year147.2%147.2%41.0%34.1%38.9%29.9%
5 Year-37.1%-37.1%38.1%26.4%71.3%52.8%

Price Volatility Vs. Market

How volatile is CV Sciences's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is CV Sciences undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CVSI ($0.66) is trading below our estimate of fair value ($2.22)

Significantly Below Fair Value: CVSI is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CVSI is unprofitable, so we can't compare its PE Ratio to the US Personal Products industry average.

PE vs Market: CVSI is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CVSI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CVSI is overvalued based on its PB Ratio (2.6x) compared to the US Personal Products industry average (2.4x).


Next Steps

Future Growth

How is CV Sciences forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

73.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CVSI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CVSI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CVSI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CVSI's revenue (11.7% per year) is forecast to grow faster than the US market (9.3% per year).

High Growth Revenue: CVSI's revenue (11.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CVSI's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has CV Sciences performed over the past 5 years?

19.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CVSI is currently unprofitable.

Growing Profit Margin: CVSI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CVSI is unprofitable, but has reduced losses over the past 5 years at a rate of 19.8% per year.

Accelerating Growth: Unable to compare CVSI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CVSI is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (17.5%).


Return on Equity

High ROE: CVSI has a negative Return on Equity (-48.71%), as it is currently unprofitable.


Next Steps

Financial Health

How is CV Sciences's financial position?


Financial Position Analysis

Short Term Liabilities: CVSI's short term assets ($27.2M) exceed its short term liabilities ($12.5M).

Long Term Liabilities: CVSI's short term assets ($27.2M) exceed its long term liabilities ($9.6M).


Debt to Equity History and Analysis

Debt Level: CVSI is debt free.

Reducing Debt: CVSI has no debt compared to 5 years ago when its debt to equity ratio was 0.07%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CVSI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if CVSI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is CV Sciences's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CVSI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CVSI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CVSI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CVSI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CVSI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.4yrs

Average management tenure


CEO

Joe Dowling (63 yo)

2.25yrs

Tenure

US$2,766,471

Compensation

Mr. Joseph D. Dowling, also known as Joe, has been its Chief Executive Officer at CV Sciences, Inc. since May 31, 2018 and Secretary since August 25, 2014. Mr. Dowling served as Chief Financial Officer at ...


CEO Compensation Analysis

Compensation vs Market: Joe's total compensation ($USD2.77M) is above average for companies of similar size in the US market ($USD607.19K).

Compensation vs Earnings: Joe's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Joseph Dowling
CEO, Secretary & Director2.25yrsUS$2.77m0.015%
$ 9.9k
Joerg Grasser
Chief Financial Officer1.42yrsUS$1.38mno data
Douglas MacKay
Senior VP of Scientific & Regulatory Affairs1.42yrsno datano data

1.4yrs

Average Tenure

47yo

Average Age

Experienced Management: CVSI's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Joseph Dowling
CEO, Secretary & Director2.25yrsUS$2.77m0.015%
$ 9.9k
Paul Blake
Independent Director0.83yrUS$220.43k0.013%
$ 8.5k
James McNulty
Independent Director4.58yrsUS$120.00k1.54%
$ 1.0m
Terri Graham
Independent Director1yrUS$225.55kno data
Timothy Ziegenfuss
Member of Advisory Boardno datano datano data
Jeffrey Anshel
Member of Advisory Boardno datano datano data
Aimee Shunney
Member of Advisory Boardno datano datano data
Alexandros Makriyannis
Member of Advisory Boardno datano datano data
Michael Lewis
Member of Advisory Boardno datano datano data
John Hicks
Member of Advisory Boardno datano datano data
Joseph Maroon
Independent Director2yrsUS$50.00k0.74%
$ 489.1k
Elizabeth Altman
Independent Director0.83yrUS$225.74k0.0012%
$ 782.0

1.5yrs

Average Tenure

66.5yo

Average Age

Experienced Board: CVSI's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CVSI insiders have sold more shares than they have bought in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

CV Sciences, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CV Sciences, Inc.
  • Ticker: CVSI
  • Exchange: OTCPK
  • Founded: 2010
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$66.274m
  • Shares outstanding: 100.42m
  • Website: https://www.cvsciences.com

Number of Employees


Location

  • CV Sciences, Inc.
  • 10070 Barnes Canyon Road
  • San Diego
  • California
  • 92121
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CVSIOTCPK (Pink Sheets LLC)YesCommon StockUSUSDSep 2011

Biography

CV Sciences, Inc. operates as a life science company. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets hemp-bas ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/04 00:39
End of Day Share Price2020/08/03 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.